Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics - 20 Year Stock Price History | CORT

Historical daily share price chart and data for Corcept Therapeutics since 2004 adjusted for splits and dividends. The latest closing stock price for Corcept Therapeutics as of April 30, 2024 is 23.32.
  • The all-time high Corcept Therapeutics stock closing price was 33.80 on September 14, 2023.
  • The Corcept Therapeutics 52-week high stock price is 34.27, which is 47% above the current share price.
  • The Corcept Therapeutics 52-week low stock price is 20.84, which is 10.6% below the current share price.
  • The average Corcept Therapeutics stock price for the last 52 weeks is 25.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Corcept Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 23.6582 24.1600 27.4600 21.1000 23.3200 -28.20%
2023 25.3578 20.1700 33.8000 19.2000 32.4800 59.92%
2022 23.7509 20.3400 29.9600 16.5300 20.3100 2.58%
2021 22.4923 26.0900 30.5600 17.1000 19.8000 -24.31%
2020 15.8917 12.0600 27.3000 10.1100 26.1600 116.20%
2019 12.4494 13.8200 16.9600 9.7800 12.1000 -9.43%
2018 15.7640 18.1400 25.5000 11.2900 13.3600 -26.02%
2017 13.1858 7.3600 20.7200 7.1100 18.0600 148.76%
2016 5.6999 4.6600 9.7400 3.2800 7.2600 45.78%
2015 4.8432 3.1200 7.1600 2.8100 4.9800 66.00%
2014 3.0302 3.3700 4.4400 1.7400 3.0000 -6.54%
2013 1.8782 1.4800 3.2100 1.4800 3.2100 124.48%
2012 3.2145 3.5000 4.4900 1.2900 1.4300 -58.19%
2011 3.7090 3.9600 4.9900 2.5700 3.4200 -11.40%
2010 3.2694 2.7800 4.4600 2.5100 3.8600 38.85%
2009 1.3226 1.3500 2.9000 0.7500 2.7800 172.55%
2008 2.1185 2.9800 3.7900 0.9100 1.0200 -66.99%
2007 2.2662 1.2000 5.1000 0.7100 3.0900 151.22%
2006 3.3517 3.6400 6.1500 0.7000 1.2300 -66.30%
2005 4.9023 6.0800 6.4100 3.4800 3.6500 -41.60%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.427B $0.482B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.830B 29.93
Chugai Pharmaceutical (CHGCY) Japan $52.113B 23.29
Takeda Pharmaceutical (TAK) Japan $41.396B 6.71
Merck (MKGAF) Germany $20.808B 19.63
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Sandoz Group AG (SDZNY) Switzerland $14.602B 0.00
Shionogi (SGIOY) Japan $13.688B 12.28
Neurocrine Biosciences (NBIX) United States $13.686B 56.83
United Therapeutics (UTHR) United States $10.396B 11.81
Catalent (CTLT) United States $10.107B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.755B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.982B 7.08
Revolution Medicines (RVMD) United States $6.356B 0.00
Ionis Pharmaceuticals (IONS) United States $6.014B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.342B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.451B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.803B 0.00
Summit Therapeutics (SMMT) United States $2.759B 0.00
PTC Therapeutics (PTCT) United States $2.466B 0.00
Indivior (INDV) United States $2.421B 11.48
Dyne Therapeutics (DYN) United States $2.181B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.947B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.839B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.835B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.819B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.776B 18.35
Avadel Pharmaceuticals (AVDL) Ireland $1.645B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Ardelyx (ARDX) United States $1.497B 0.00
Soleno Therapeutics (SLNO) United States $1.492B 0.00
Xencor (XNCR) United States $1.291B 0.00
4D Molecular Therapeutics (FDMT) United States $1.224B 0.00
Pacira BioSciences (PCRX) United States $1.221B 12.15
Ironwood Pharmaceuticals (IRWD) United States $1.213B 11.40
Collegium Pharmaceutical (COLL) United States $1.208B 7.43
Cronos Group (CRON) Canada $1.123B 0.00
Cassava Sciences (SAVA) United States $0.958B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.919B 0.00
Relay Therapeutics (RLAY) United States $0.863B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.852B 0.00
ARS Pharmaceuticals (SPRY) United States $0.843B 0.00
Sage Therapeutics (SAGE) United States $0.839B 0.00
Enliven Therapeutics (ELVN) United States $0.817B 0.00
USANA Health Sciences (USNA) United States $0.799B 12.94
Ocular Therapeutix (OCUL) United States $0.733B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.728B 0.00
Silence Therapeutics (SLN) United Kingdom $0.654B 0.00
Savara (SVRA) United States $0.633B 0.00
Siga Technologies (SIGA) United States $0.624B 9.24
Exscientia (EXAI) United Kingdom $0.598B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.594B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.520B 0.00
Verve Therapeutics (VERV) United States $0.504B 0.00
KalVista Pharmaceuticals (KALV) United States $0.479B 0.00
ProKidney (PROK) United States $0.474B 0.00
Altimmune (ALT) United States $0.464B 0.00
Korro Bio (KRRO) United States $0.456B 0.00
Larimar Therapeutics (LRMR) United States $0.440B 0.00
Lexeo Therapeutics (LXEO) United States $0.410B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.410B 0.00
Tourmaline Bio (TRML) United States $0.406B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.389B 0.00
Esperion Therapeutics (ESPR) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.366B 20.47
Harrow (HROW) United States $0.361B 0.00
Heron Therapeutics (HRTX) United States $0.349B 0.00
Fractyl Health (GUTS) United States $0.324B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Bioventus (BVS) United States $0.314B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Aquestive Therapeutics (AQST) United States $0.306B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.295B 0.00
Black Diamond Therapeutics (BDTX) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.291B 0.00
ESSA Pharma (EPIX) Canada $0.284B 0.00
Nanobiotix S.A (NBTX) France $0.275B 0.00
Nektar Therapeutics (NKTR) United States $0.268B 0.00
Akebia Therapeutics (AKBA) United States $0.264B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.249B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Foghorn Therapeutics (FHTX) United States $0.232B 0.00
Conduit Pharmaceuticals (CDT) United States $0.222B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Avita Medical (RCEL) United States $0.217B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Acrivon Therapeutics (ACRV) United States $0.206B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Eliem Therapeutics (ELYM) United States $0.197B 0.00
Telomir Pharmaceuticals (TELO) United States $0.196B 0.00
Century Therapeutics (IPSC) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
Incannex Healthcare (IXHL) Australia $0.183B 0.00
Profound Medical (PROF) Canada $0.182B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Prelude Therapeutics (PRLD) United States $0.159B 0.00
Regulus Therapeutics (RGLS) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.150B 0.00
CytoDyn (CYDY) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 12.97
Cardiol Therapeutics (CRDL) Canada $0.137B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.123B 2.59
Karyopharm Therapeutics (KPTI) United States $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
FibroGen (FGEN) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.110B 0.00
Inotiv (NOTV) United States $0.099B 0.00
OptiNose (OPTN) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.084B 6.81
ProPhase Labs (PRPH) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Journey Medical (DERM) United States $0.074B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.95
Mural Oncology (MURA) Ireland $0.063B 0.00
Jaguar Animal Health (JAGX) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Surrozen (SRZN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
DURECT (DRRX) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.027B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
TherapeuticsMD (TXMD) United States $0.022B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Avalo Therapeutics (AVTX) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.23